Revolutionizing Medication Safety Reviews with IntractMD™ for Medicare
Resolve Medical, LLC has unveiled a groundbreaking platform, IntractMD™, aimed at revolutionizing medication safety reviews just as Medicare updates its quality measures for 2025.
This innovative system consolidates prescription data, dietary supplements, vitamins, and food interactions into a unified process, offering significant benefits for healthcare stakeholders including health plans and pharmacy benefit managers. With the Medicare adjustments set to double the number of eligible beneficiaries for Comprehensive Medication Reviews from approximately 3.6 million to about 7.1 million, the demand for more precise medication management has never been greater. The looming changes also bring new quality measures for Part D that will affect the 2027 Medicare Star Ratings, particularly focusing on medication safety in relation to opioids, benzodiazepines, and anticholinergic medications in older adults.
Overcoming Medication Management Challenges
One notable challenge highlighted by Resolve Medical’s founder, Tom Lash, is capturing accurate data on non-prescription product usage. This information is vital for building a comprehensive view of a patient's medication regimen. Lash noted the gap in standard pharmacy records that often overlook supplements and over-the-counter products, thereby affecting pharmacists' ability to make informed decisions. Lash explains, “Pharmacists often need reliable information on supplements and over-the-counter products which may not appear in standard pharmacy records.”
A Comprehensive Tool for Healthcare Professionals
IntractMD™ addresses this challenge by offering a suite of applications tailored to different healthcare roles, equipped with a sophisticated drug interaction analysis model. This model utilizes a broad spectrum of medications, standardized terminology via RxNorm, and FDA-approved resources for interaction content. Among its features are patient interaction tools, population screening utilities for health plans, and clinical workflow applications dedicated to medication management, including a newly pilot-tested deprescribing review.
Healthcare professionals can also benefit from a no-cost, 60-day pilot program offered by Resolve Medical, which does not require software installation and allows various entities to explore the platform on their cloud infrastructure. By providing application results in English and Spanish, IntractMD™ ensures effective communication of medication risks, enhancing overall patient care.
Resolve Medical, based in Cleveland, continues to advance medication safety through its cutting-edge technological solutions, supporting comprehensive medication risk evaluations. Their introduction of IntractMD™ is a promising development for the industry, aiming to streamline medication safety as Medicare policy evolves.